We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!

Proteus Biomedical, a company that brings together device, pharmaceutical and biotech companies to find answers for cardiac and heart failure patients, has brought in $25.4 million of an anticipated $35 million round of equity, according to a filing with the SEC. Based in Redwood City, Calif., the company is backed the Carlyle Group and Essex Woodlands Venture Partners among others.

VentureBeat's mission is to be a digital town square for technical decision-makers to gain knowledge about transformative enterprise technology and transact. Learn more about membership.